跳至主要内容
临床试验/NL-OMON56664
NL-OMON56664撤回不适用

Markers of Oxidative Stress from Supplemental Oxygen in critically-ill children - MOSSO2

Academisch Medisch Centrum0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 11(—)

入选标准

  • Main study population:
  • - Age below 24 months
  • - Proven VLRTI
  • - Endotracheal intubation
  • - Mechanical ventilation
  • - Informed consent obtained for the complete study protocol (3 days) of
  • exposure to two different oxygen supplementation protocols on separate days
  • combined with non-invasive exhaled-breath measurements and a single
  • non-endoscopic bronchoalveolar lavage at the final day of study after
  • confirmation of comprehension of the Dutch language
  • Non-infected control population:
  • - Age below 12 years
  • - Endotracheal intubation
  • - Mechanical ventilation
  • - No signs of infection (fever, temperature >38.5 C) and no respiratory
  • symptoms (cough, wheeze, snotty) present at moment of intubation
  • - No reported respiratory symptoms in the last seven days prior to pediatric
  • intensive care unit admission
  • - Informed consent obtained for the partial study protocol (1 day) of exposure
  • to the liberal oxygenation protocol combined with non-invasive exhaled-breath
  • measurements after confirmation of comprehension of the Dutch language

排除标准

  • Main study population:
  • - Age above 24 months
  • - Active infection with SARS-CoV-2
  • - Contra-indication for high flow or low flow oxygen supplementation (e.g.
  • previous bleomycin treatment, carbon monoxide intoxication)
  • - No consent
  • - Receiving HFO
  • - Receiving nitric oxide treatment for pulmonary hypertension
  • - In need for specific oxygen saturation targets based on underlying congenital
  • heart disease
  • Non-infected control population:
  • - Age above 12 years
  • - Proven ongoing pulmonary infection
  • - Symptoms of a present or recent infection (temperature >38.5 C) or
  • respiratory symptoms (cough, wheeze, snotty) in the last seven days prior to
  • pediatric intensive care unit admission.
  • - Contra-indication for high flow oxygen supplementation (e.g. previous
  • bleomycin treatment)
  • - No consent

研究者

相似试验

Markers of Oxidative Stress from Supplemental Oxygen... | 临床试验